Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,459.70.
30 Oct: open ₹3,479.00, high ₹3,619.90, low ₹3,460.50
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43,846 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,55826.6% delivered
Ajanta Pharma share news and announcements
812 announcements, routine notices left out, newest first. Page 4 of 17.
May 2024
2 May · Disclosure
2 May · Corporate action
2 May · Board meeting
2 May · Results
Apr 2024
23 Apr · Analysts
Feb 2024
2 Feb · Analysts
Jan 2024
31 Jan · Disclosure
31 Jan · Corporate action
31 Jan · Results
25 Jan · Analysts
25 Jan · Corporate action
23 Jan · Analysts
File name: “StockExchangeIntimationQ3FY2024”
23 Jan · Analysts
8 Jan · Analysts
Oct 2023
31 Oct · Results
19 Oct · Analysts
19 Oct · Board meeting
Sep 2023
14 Sep · Legal
The exchange asked on 13 Sep 2023
Aug 2023
17 Aug · Analysts
Jul 2023
27 Jul · Updates
27 Jul · Results
24 Jul · Corporate action
24 Jul · Analysts
18 Jul · Meeting
14 Jul · Board meeting
Jun 2023
26 Jun · Updates
16 Jun · Meeting
May 2023
29 May · Updates
7 May · Results
5 May · Updates
5 May · Results
5 May · Board meeting
Apr 2023
27 Apr · Analysts
27 Apr · Board meeting
Mar 2023
28 Mar · Buyback
28 Mar · Buyback